Nanotechnology to achieve Cost Efficiencies within Global Medical Devices Value Chain (TechVision)

Leading the Way Forward for OEMs Streamlining their Global Medical Devices Value Chain

USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

Development of nanotechnology-based medical devices enables major cost reduction across the medical device value chain, as it offers very high bargaining power to suppliers of medical device OEMs (original equipment manufacturers). This research service (RS) analyzes the need for adoption of nanotechnologies in the medical devices industry, which are poised to enable creation of innovative medical device technologies that boost the overall quality of life for patients, and care providers. The RS evaluates the various technology developments within the major market segments within the global medical devices industry, such as drug delivery systems, in-vivo imaging, medical implants, and in-vitro diagnostics. From

Table of Contents

1.0 Executive Summary1.1 Scope of Research1.2 Research Methodology2.0 Key Findings2.1 Broad Commercial Application of Nanotechnology in Medical Coatings2.2 Very Low Commercial Impact of Therapeutic Applications of Nanotechnology in Non-oncology Sectors2.3 Nanoscale Materials for Medical Devices Offer Potential to Increase Value Offered to Care Consumers3.0 Industry Overview3.1 Nanomanufacturing Enable Production of Cellular-scale Sensors for High-resolution Measurements3.2 Hydroxyapatite-coated Titanium and Tantalum Implants Offer High Commercial Market Potential3.3 Nanocoatings Increase Biocompatibility of Medical Implants and Reduce Re-hospitalization3.4 Nanolithography is One of the Most Widely Investigated Manufacturing Technique in the Past Decade4.0 Trends Assessment4.1 Research Collaboration Improves Technical Know-how on 3D Printing of Stem Cells4.2 Nanotechnologies Alleviate Supplier's Compromise on Quality to Cost Reduction4.3 Nanomaterials Addresses the Challenge of Bacterial Resistance to Traditional Antimicrobial Treatment5.0 Global R&D Network Analysis5.1 Joint Collaboration with International Research Teams Improve Precision of Rapid Prototyping5.2 Commercialized Therapeutic Applications of Nanotechnology Supersede Diagnostic Applications5.3 Nano-functionalization Has Very Low Impact in Increasing Biocompatibility of Cardiac Implants5.4 Global Regulatory Scenarios Influence Production/Testing in Drug Delivery and in vitro Diagnostics6.0 Strategic Management of R&D6.1 Nano-based Power Supplies for in vivo Medical Implants Reduce Surgical Replacement Costs6.2 High Potential Licensing Agreements in Dendrimer-enhanced Nanoscale Polymer Technologies6.3 Technology Licensing Opportunities in Fabrication of Nanomaterial-based Biosensors6.4 Focus on Non-oncology Applications are Poised to Support Market Share Growth for Companies7.0 Analyst Insights7.1 Companies Rely on Strategic Partnerships with Leading Industry Participants to Gain Access to Emerging Markets7.2 Nanotech Offers Potential for Non-healthcare Market Leaders to Diversify into Medical Devices Sector7.3 Surface Coated Nanoparticles for Radiotherapy Have High Potential for Both Revenue and Value Growth7.4 Out-innovate Other Companies to Maintain Market Position8.0 Key Recommendations8.1 High Prospects for Development of Nanoviricides for Treating Viral Diseases by 20209.0 Patent Analysis and Database of Industry Contacts9.1 Granted and Applied Patents for Drug Delivery and Medical Implants Remain Proportional to Each Other over the Past Two Decades9.2 Key Patents: Nanoparticle Drug Delivery System and Method of Treating Cancer and Neurotrauma9.3 Key Patent: Synthesis of Fluorescent Noble Metal Nanoparticles9.4 Key Patent: Nanoparticles for Magnetic Resonance Imaging Tracking and Methods of Manufacturing10.0 Database of Key Industry Contacts10.1 List of Key Industry ParticipantsLegal Disclaimer11.0 The Frost & Sullivan Story11.1 The Frost & Sullivan Story11.2 Value Proposition: Future of Your Company & Career11.3 Global Perspective11.4 Industry Convergence11.5 360º Research Perspective11.6 Implementation Excellence11.7 Our Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.